1 year return (CAGR)
51.00%
Denali Therapeutics Inc Exchange (NASDAQ, USD)
DNLI
20.47
-0.41 (-2.04%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-6.21%
5 year return (CAGR)
-17.51%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.15B
Price/Sales
874.64
Ent value
3.27B
Price/Book
3.77
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 20.07 |
| Daily high | 20.16 |
| Daily low | 19.56 |
| Daily Volume | 2.96M |
| All-time high | 93.56 |
| 1y analyst estimate | 35.75 |
| Beta | 1.00 |
| EPS (TTM) | -2.73 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| DNLI | S&P500 | |
| Current price drop from All-time high | -78.12% | -1.38% |
| Highest price drop | -87.74% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -52.21% | -10.68% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 1441 days | 1805 days |
News
